Perrigo Predicts Upturn On OTC Private Label Breadth, Depth And Bandwidth
Executive Summary
Perrigo counts on its OTC private label dominance to thwart new store brand entries and give it a leg-up in e-commerce sales, which are growing at 50% year-to-year. Private label is "a distinctly different business than the national brand space," says consumer health executive Jeffrey Needham.
You may also be interested in...
Perrigo CEO Takes Faith In Rx Generics Business To Exit Door With Him
Private label OTC business is likely to be strengthened as Perrigo’s core, as CEO Hendrickson announces retirement shortly after hedge fund investor Starboard Value, pushing to divest the Rx business, built a five-seat block on Perrigo's board.
Perrigo OTC Growth Rides Innovation Path Wider Than Switches
When Perrigo executives confirmed their faith during an earnings briefing in the firm's OTC private label as its primary revenue driver, some analysts wanted more as assurance that the business will continue stabilizing the firm.
Navigating Amazon: E-Commerce Giant Critical For OTC Drug Sales
As Amazon emerges as the leading search engine for information about consumer packaged goods products, OTC drug and other consumer health product firms should establish a presence, even if they expect not to sell much, says BeeKeeper consultancy's Lynn Graham.